VALIDOGEN to co-present with Boehringer Ingelheim at BPI International US West 2019, 11 - 14 March, Santa Clara, CA
Iskandar Dib, Principal Scientist Process Development & Analytics, VALIDOGEN GmbH
Stefan Krahulec, Senior Manager Technology & Innovation, Boehringer Ingelheim RCV GmbH & Co KG
"Best practice model for collaborative end to end process development and manufacturing using P. pastoris"
Monday, 11 March, 3:30 - 4:00 pm
BPI's Pre-Conference Symposium on Microbial Manufacturing
This joint talk will illustrate how the versatile genetic toolbox UNLOCK PICHIA, VALIDOGEN’s established strain generation strategies and seamless process transfer between the two companies enable fast track development from gene to GMP. In a case study example, Iskandar and Stefan will discuss strain and process improvements made, process development for Phase I and successful transfer to GMP scale.
Iskandar and Stefan will also participate in the "Thought Leaders Discussion: Where Is, Microbial Production Going?" on March 11, 9:30 - 10:00 am.
Topics to be discussed will cover the role of microbial hosts in the bioproduction space, technologies and product advances that will change the market for microbial production and drive industry away from traditional CHO platforms as well as the development of microbial platform approaches.